Papers: 2 May 2014 - 9 May 2014
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review.
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.
Trunk kinematics during walking in persons with multiple sclerosis: The influence of body weight support.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?
Intermittent alien hand syndrome and callosal apraxia in multiple sclerosis: implications for interhemispheric communication.